Cambridge – October 30, 2026 -- LabCentral, C10 Labs and Innovation Centre Denmark Boston will host Entangled 2026 on November 19 at The Platform in Kendall Square, convening more than 250 leaders from biotech, deep tech, investment, academia and government, including a delegation of about 50 from Denmark.

BRANFORD, CT – October 29, 2026 -- Urologic Design closed an oversubscribed $1.2 million pre-seed round to move its patented urinary incontinence device toward a first-in-human study.

Angel Investor Forum leads a syndicate of regional and university-linked backers

Angel Investor Forum, described as Connecticut's primary angel group, led the equity round. HBS Alumni Angels of Boston, Haven Founders Fund, Connecticut Innovations and Yale Angels joined, along with several individual investors.

MILWAUKEE – October 29, 2026 -- The Society for Immunotherapy of Cancer (SITC) received almost 1,200 abstract submissions for 2026 and will showcase eight selected studies at a virtual press briefing on Wednesday, Nov. 4, from 12 to 1:30 p.m. MT.

Weihai, China – October 29, 2026 -- Nine of the 20 labelers in the FDA's GUDID database for topical tissue adhesives hold no clearance of their own, yet they account for 44 of 97 device records (45%), according to a September 2026 supplier-landscape report from VEMERIX, the international brand of Weihai Medison Medical Equipment Co., Ltd. The company has distilled the findings into a document checklist for buyers sourcing medical cyanoacrylate adhesives in bulk.

Austin – October 29, 2026 -- National Veterinary Associates (NVA) Vice President of Science and Clinical Advancement Tracy Hill, DVM, PhD, DACVIM (SAIM), has been named to Morris Animal Foundation's FY27 Feline Scientific Advisory Board (SAB). The appointment extends her clinical research work beyond NVA's network of more than 1,200 general practice, specialty and emergency veterinary hospitals.

Burlington – October 29, 2026 -- The U.S. Food and Drug Administration has approved an expanded indication for Instylla's Embrace Hydrogel Embolic System (HES), covering embolization of peripheral arterial bleeds in vessels of 6 mm or less. Embrace HES is now the first and only liquid embolic approved for both peripheral arterial bleeds and hypervascular tumors, according to the privately held company. The product is commercially available in the U.S.

DALLAS – October 29, 2026 -- Nanoscope Therapeutics will field four executives across six sessions at Advanced Therapies USA 2026 in Boston on November 4-5, as its optogenetic gene therapy MOGENRY (sonpiretigene isteparvovec; MCO-010) awaits decisions from the U.S. FDA and Japan's PMDA. The conference, held at the Hynes Convention Center, brings together cell and gene therapy developers, manufacturers, investors and commercial leaders.

SHANGHAI – October 29, 2026 -- United Imaging Healthcare (688271.SH) posted revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year, as international sales grew 50.30%.

Third-quarter revenue reached RMB 3.53 billion. Net profit attributable to shareholders rose 13% year-on-year to RMB 138 million.

International sales reach 28.31% of group revenue

Overseas revenue totaled RMB 3.00 billion in the period. Its share of total revenue rose 5.82 percentage points from a year earlier to 28.31%.

TOKYO – October 29, 2026 -- The Global Health Innovative Technology (GHIT) Fund has committed about JPY 1.06 billion (USD 6.8 million) to nine R&D projects covering drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging infectious diseases such as Ebola.

CONSHOHOCKEN, Pa. – October 28, 2026 -- Suvoda has added Lyft, Uber Health and Bolt rideshare access to Greenphire Travel, targeting a logistical barrier that 49% of disrupted participants in the latest CISCRP study cited: travel to the study clinic.